Lupin Digital Health launches AI-powered cardiometabolic wellness platform

Lupin Digital Health Limited, a wholly-owned subsidiary of Lupin Limited, has launched VITALYFE™, an AI-powered cardiometabolic wellness platform. This new offering aims to address heart health among India's workforce, extending the company's expertise from cardiac recovery to preventive wellness. VITALYFE™ builds on the foundation of LYFE, India's first CDSCO-approved Class C software medical device for critical cardiac conditions.

The platform utilizes artificial intelligence, behavioral science, and computer-vision technology to identify early risks and provide personalized, non-medical interventions for heart aging. Key features include a "Heart Age Journey" to calculate and reduce heart age, "Snap & Track" for photo-based nutrition analysis, and "Camera-Guided Exercise" for real-time feedback on form accuracy. It also offers a "Guided Meditation Library" and "Gamified Challenges & Rewards" to foster healthy habits.

VITALYFE™ is available exclusively through insurers, brokers, and employers, allowing organizations to integrate cardiometabolic wellness into their health benefits. It enables the integration of annual health-check data, facilitates company-wide challenges, and provides anonymized dashboards for tracking improvements in heart age, engagement, and activity. The platform complies with India's Digital Personal Data Protection (DPDP) Act and is ISO 27001-certified.